You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial

Article info

Article menu

Download PDFPDF

XML
Health economics
Protocol
Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial

Authors

  • Victoria Mailen Arfuch Unitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, SpainDepartment of Pediatrics, Obstetrics and Gynecology, and Preventive Medicine, Universitat Autonoma de Barcelona, Barcelona, Catalunya, Spain PubMed articlesGoogle scholar articles
  • Carina Aguilar Martín Unitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, SpainUnitat d’Avaluació, Direcció d’Atenció Primària Terres de l’Ebre, Institut Català de la Salut, Tortosa, Catalunya, Spain PubMed articlesGoogle scholar articles
  • Anna Berenguera Central Research Unit, IDIAP Jordi Gol, Barcelona, Catalunya, SpainDepartment of Pediatrics, Obstetrics and Gynecology, and Preventive Medicine, Universitat Autonoma de Barcelona, Barcelona, Catalunya, Spain PubMed articlesGoogle scholar articles
  • Rosa Caballol Angelats Equip d’Atenció Primària Tortosa Est, Institut Català de la Salut, Tortosa, Catalonia, SpainUnitat d’Expertesa en Sindromes de Sensibilització Central Terres de l’Ebre, Institut Català de la Salut, Tortosa, Catalonia, Spain PubMed articlesGoogle scholar articles
  • Noèlia Carrasco-Querol Unitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, Spain PubMed articlesGoogle scholar articles
  • Gemma González Serra Unitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, SpainUnitat d’Expertesa en Sindromes de Sensibilització Central Terres de l’Ebre, Institut Català de la Salut, Tortosa, Catalonia, Spain PubMed articlesGoogle scholar articles
  • Maria Cinta Sancho Sol Unitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, SpainUnitat d’Expertesa en Sindromes de Sensibilització Central Terres de l’Ebre, Institut Català de la Salut, Tortosa, Catalonia, Spain PubMed articlesGoogle scholar articles
  • Immaculada Fusté Anguera Equip d’Atenció Primària Tortosa Est, Institut Català de la Salut, Tortosa, Catalonia, SpainUnitat d’Expertesa en Sindromes de Sensibilització Central Terres de l’Ebre, Institut Català de la Salut, Tortosa, Catalonia, Spain PubMed articlesGoogle scholar articles
  • José Fernández Sáez Unitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, Spain PubMed articlesGoogle scholar articles
  • Alessandra Queiroga Gonçalves Unitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, SpainUnitat Docent de Medicina de Família i Comunitària Tortosa-Terres de L‘Ebre, Institut Català de la Salut, Tortosa, Catalonia, Spain PubMed articlesGoogle scholar articles
  • Marc Casajuana Central Research Unit, IDIAP Jordi Gol, Barcelona, Catalunya, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Mr Marc Casajuana; mcasajuana{at}idiapjgol.org
View Full Text

Citation

Arfuch VM, Aguilar Martín C, Berenguera A, et al
Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial
BMJ Open 2021;11:e043562. doi: 10.1136/bmjopen-2020-043562

Publication history

  • Received August 7, 2020
  • Revised November 19, 2020
  • Accepted November 27, 2020
  • First published February 5, 2021.
Online issue publication 
March 16, 2023
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.